Motor Learning-based Clinical Pilates Rehabilitation Protocol for Patients with Parkinson's Disease
Motor Learning-based Clinical Pilates Rehabilitation Protocol for Patients with Parkinson's Disease, Called @parkinsonpilates: Randomised Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Fahriye Çoban, PT, MSc
- Phone Number: 0903926602000
- Email: fcoban@eul.edu.tr
Study Contact Backup
- Name: Beliz Belgen Kaygısız, PT, PhD
- Phone Number: 0903926602000
- Email: bkaygisiz@eul.edu.tr
Study Locations
-
-
-
Mersin, Turkey
- European University of Lefke
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having modified Hoehn & Yahr Scale grade 2-3 symptoms
- Be over 45 years old
- Having a score of 24 or 24< on the Mini Mental test
- To be able to read and write in Turkish
- Having at least 2 years Parkinson's Disease
Exclusion Criteria:
- Serious mental and psychological disorder
- Significant musculoskeletal disorders
- Lower extremity deformation
- Having another neurological disease
- Drug or dose change during treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Motor learning based clinical pilates
Participants in this group will receive training for 60 minutes 2 times a week for 12 weeks and will be followed up with the same assessments at the 3rd months after the treatment.
|
The exercises will be created as function and goal.
At least one stimulus will be given during each exercise (visual, tactile, auditory or vestibular).
2 different levels were determined for 3 months of treatment, according to the months.
As the level increased, the intensity of the exercise increased.
In general, the exercise intensity was increased according to the against gravity and the decreasing in the support area.
Other Names:
|
|
Active Comparator: Conventional Physiotherapy
Participants in this group will receive training for 60 minutes 2 times a week for 12 weeks and will be followed up with the same assessments at the 3rd months after the treatment.
|
This exercise program will include strengthening, stretching, posture exercises, balance and gait exercises.
Aim is to improve muscle strength and prevent shortness of muscles.
Also, balance and gait exercise aim to improve walking capacity.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nelson Foot Reaction Test
Time Frame: 5 minutes
|
This test is measured using a ruler and this gives the simple reaction time.
The participant sits against the wall with the toe at a distance of 2.5 cm and the heel at a distance of 5 cm from the wall.
The test administrator holds the reaction ruler between the wall and the participant's foot and releases the ruler as soon as the participant is ready.
The participant tries to hold the falling ruler by squeezing it against the wall.
It will be measured 20 times.
Five best and five worst values will be discarded and the average of the remaining measurement will be taken.
|
5 minutes
|
|
Gait and Balance Scale (Untimed Tasks)
Time Frame: 15 minutes
|
Gait and Balance Scale (GABS) consists of historical information and examination of 14 different gait and balance parameters designed to assess the severity of these functional domains.
Thirty-five patients with Parkinson's disease (PD), Hoehn and Yahr stages 1 - 3, were tested.
Items 1 to 17 GABS are scored on a scale of 0 to 4 (0 being normal and 4 being the worst).
Items 18- 24 are scored on a scale 0 to 1 or 0 to 2 (0 being normal and 1 or 2 being abnormal).
|
15 minutes
|
|
Gait and Balance Scale (Timed Tasks - Cadence)
Time Frame: 2 minutes
|
Gait and Balance Scale (GABS) consists of timed tasks to assess gait speed and the 'up-and-go' test.
Timed tasks provide valuable information about the gait cycle by measuring speed of walking, variation between the normal and fast gait speed, stand-walk-sit time and cadence.
|
2 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional reach test
Time Frame: 5 minutes
|
A balance test designed to measure stability limits.
The patient is asked to raise the dominant arm 90 ° and place it at the shoulder level and extend as far as it can go forward, without loss of movement or balance in the feet.
Reduced ability to reach indicates an increased risk of falling in the future.
|
5 minutes
|
|
Timed-up and Go test
Time Frame: 5 minutes
|
When the command is given, the patient gets up from a normal chair, walks 3 meters, turns and walks back to the chair and sits down.
The time starts when the command is given and ends when the person sits back in the chair.
|
5 minutes
|
|
Berg Balance Scale
Time Frame: 15 minutes
|
This test is used to measure a person&amp;#39;s static and dynamic balance performance.
It is effective in assessing postural control and predicting the risk of falling.
It is a 14-item test that uses 0 to 4 sequential scoring for each item.
The total score range is from 0 to 56 and a higher score indicates a better balance.
|
15 minutes
|
|
The Unified Parkinson&amp;#39;s Disease Rating Scale (UPDRS) III. Subscale
Time Frame: 15 minutes
|
The severity of motor symptoms will be assessed with the UPDRS III.
(1) bradykinesia (finger taps, hand movements, rapid alternating movements of hand, leg agility, body bradykinesia and hypokinesia); (2) rigidity; (3) tremor (tremor at rest, action or postural tremor of hands); and (4) axial symptoms (arising from chair, posture, gait, postural stability).
|
15 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Beliz Belgen Kaygısız, PT, PhD, European University of Lefke
- Principal Investigator: Fahriye Çoban, PT, MSc, European University of Lefke
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BAYEK022.05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.